- Home
- Industry Reports
- Diagnostics
- Healthcare
- Colorectal Cancer Screening Test Market- Size, Outlook, Trends and Forecast (2024 – 2032)
Colorectal is also known as colon cancer and bowel cancer which the third common cancer among the big four tumour types that affect both men and women. It is the second most common cancer after lung cancer which was disclosed by world health organisation. The colon and rectal were present in the large intestine that had an essential role in the body to process the waste. The global colorectal cancer screening tests market is expected to grow from USD 0.50 billion in the year 2012 and is expected to reach approximately USD 0.85 billion by 2023, with a CAGR of 5.39% during the forecast period.
Global Colorectal Cancer Screening Tests Market Share:
The global colorectal cancer screening tests market share is divided by Product that is further divided into several tests. Among these tests DNA screening test is expected to have the highest revenue in the forecast period.
Global Colorectal Cancer Screening Tests Market Size:
North America has the most substantial colorectal cancer screening tests due to the presence of highest geriatric population. The advent of the government controls has made compulsory use of cancer screening tests and the novel minimally invasive tests were increased which are useful for the screening of colorectal cancer.
Global Colorectal Cancer Screening Tests Market Growth:
The massive diagnostic plans were implemented with the favourable government support and improved awareness. The governments of the U.S and European governments have issued guidelines for the ore to determine cancer and other associated risk levels. Due to less knowledge and lack of adequate sensitivity about the importance of diagnosis, poor compliance and high price would limit the growth of the industry over the coming years.
Global Colorectal Cancer Screening Tests Market Industry Analysis:
Product and pipeline recognise the comprehensive colorectal cancer screening tests market industry analysis. The colorectal cancers have been growing year by year. Therefore, an American Cancer society pegs increased awareness among people and the evolution of new screening methods. This had a positive influence on overall colorectal cancer market.
Global Colorectal Cancer Screening Tests Market Outlook:
The global colorectal cancer can be driven by growing population of obese people and better reimbursement policies. The act of threats to market growth is the high cost of screening tests and drugs. Rising awareness regarding the incidence of CRC and importance of diagnosis has driven the higher compliance with regular tests
Global Colorectal Cancer Screening Tests Market Trends:
R-biopharma has the latest technologies like ELISA, Enzymatic assays, Lateral flow assays, Microbiological assays, Purification columns, Ready to use media and Real-time PCR. Siemens Healthiness has a FAST Integrated Workflow technology that is used for the patient positioning.
Global Colorectal Cancer Screening Tests Market Report Research includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- R-Biopharm
- Sysmex Corporation
- Abbott Molecular Inc.
- Kyowa Medex
- Merck Millipore
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Key Market Feature
1.4 Market Outline
1.5 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Product
6.1 Fecal Occult Blood Tests
6.1.1 Guaiac FOB Stool Test
6.2.2 Immuno-FOB Agglutination Test
6.2.3 Lateral Flow Immuno-FOB Test
6.2.4 Immuno-FOB ELISA Test
6.2 Stool Biomarkers Tests
6.2.1 Cologuard
6.2.2 M2-PK Stool Test
6.3 Blood Biomarkers Tests
6.3.1 ColoSentry
6.3.2 ColoVantage
6.3.3 Epi proColon
6.3.4 mS9
6.4 Biomarker test
6.4.1 Tumor M2-PK stool test
6.4.2 Transferrin assays
6.5 CRC DNA screening test
6.5.1 Methylated gene test
6.5.2 Panel DNA test
Chapter 7 Market Segmentation by Pipeline
7.1 MarCarePlex
7.2 Cologic
7.3 Colox
7.4 miRSIGN
7.5 PanC-Dx
7.6 MeScore CRC
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company profiles
10.1 Analogic Corporation
10.1.1 Business Overview
10.1.2 Product portfolio
10.1.3 Key Strategy
10.1.4 Recent Developments
10.2 R-Biopharm
10.3 Sysmex Corporation
10.4 Abbott Molecular Inc
10.5 Kyowa Medex
10.6 Merck Millipore
10.7 Epigenomics AG
10.8 Abbott Molecular Inc
10.9 Companion Dx
10.10 Randox Laboratories
10.11 Immunostics Co
10.12 MODE Diagnostics Ltd
10.13 Siemens Healthineers
10.14 DanDrit Biotech
10.15 VolitionRX
Chapter 11 Market Estimates and Forecasts
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Product 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Pipeline 2018-2024 (USD Million)
11.1.3 Market Estimation and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Colorectal is also known as colon cancer and bowel cancer which the third common cancer among the big four tumour types that affect both men and women. It is the second most common cancer after lung cancer which was disclosed by world health organisation. The colon and rectal were present in the large intestine that had an essential role in the body to process the waste. The global colorectal cancer screening tests market is expected to grow from USD 0.50 billion in the year 2012 and is expected to reach approximately USD 0.85 billion by 2023, with a CAGR of 5.39% during the forecast period.
Global Colorectal Cancer Screening Tests Market Share:
The global colorectal cancer screening tests market share is divided by Product that is further divided into several tests. Among these tests DNA screening test is expected to have the highest revenue in the forecast period.
Global Colorectal Cancer Screening Tests Market Size:
North America has the most substantial colorectal cancer screening tests due to the presence of highest geriatric population. The advent of the government controls has made compulsory use of cancer screening tests and the novel minimally invasive tests were increased which are useful for the screening of colorectal cancer.
Global Colorectal Cancer Screening Tests Market Growth:
The massive diagnostic plans were implemented with the favourable government support and improved awareness. The governments of the U.S and European governments have issued guidelines for the ore to determine cancer and other associated risk levels. Due to less knowledge and lack of adequate sensitivity about the importance of diagnosis, poor compliance and high price would limit the growth of the industry over the coming years.
Global Colorectal Cancer Screening Tests Market Industry Analysis:
Product and pipeline recognise the comprehensive colorectal cancer screening tests market industry analysis. The colorectal cancers have been growing year by year. Therefore, an American Cancer society pegs increased awareness among people and the evolution of new screening methods. This had a positive influence on overall colorectal cancer market.
Global Colorectal Cancer Screening Tests Market Outlook:
The global colorectal cancer can be driven by growing population of obese people and better reimbursement policies. The act of threats to market growth is the high cost of screening tests and drugs. Rising awareness regarding the incidence of CRC and importance of diagnosis has driven the higher compliance with regular tests
Global Colorectal Cancer Screening Tests Market Trends:
R-biopharma has the latest technologies like ELISA, Enzymatic assays, Lateral flow assays, Microbiological assays, Purification columns, Ready to use media and Real-time PCR. Siemens Healthiness has a FAST Integrated Workflow technology that is used for the patient positioning.
Global Colorectal Cancer Screening Tests Market Report Research includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- R-Biopharm
- Sysmex Corporation
- Abbott Molecular Inc.
- Kyowa Medex
- Merck Millipore
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Key Market Feature
1.4 Market Outline
1.5 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Product
6.1 Fecal Occult Blood Tests
6.1.1 Guaiac FOB Stool Test
6.2.2 Immuno-FOB Agglutination Test
6.2.3 Lateral Flow Immuno-FOB Test
6.2.4 Immuno-FOB ELISA Test
6.2 Stool Biomarkers Tests
6.2.1 Cologuard
6.2.2 M2-PK Stool Test
6.3 Blood Biomarkers Tests
6.3.1 ColoSentry
6.3.2 ColoVantage
6.3.3 Epi proColon
6.3.4 mS9
6.4 Biomarker test
6.4.1 Tumor M2-PK stool test
6.4.2 Transferrin assays
6.5 CRC DNA screening test
6.5.1 Methylated gene test
6.5.2 Panel DNA test
Chapter 7 Market Segmentation by Pipeline
7.1 MarCarePlex
7.2 Cologic
7.3 Colox
7.4 miRSIGN
7.5 PanC-Dx
7.6 MeScore CRC
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company profiles
10.1 Analogic Corporation
10.1.1 Business Overview
10.1.2 Product portfolio
10.1.3 Key Strategy
10.1.4 Recent Developments
10.2 R-Biopharm
10.3 Sysmex Corporation
10.4 Abbott Molecular Inc
10.5 Kyowa Medex
10.6 Merck Millipore
10.7 Epigenomics AG
10.8 Abbott Molecular Inc
10.9 Companion Dx
10.10 Randox Laboratories
10.11 Immunostics Co
10.12 MODE Diagnostics Ltd
10.13 Siemens Healthineers
10.14 DanDrit Biotech
10.15 VolitionRX
Chapter 11 Market Estimates and Forecasts
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Product 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Pipeline 2018-2024 (USD Million)
11.1.3 Market Estimation and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.